Both instruments are compromised. Fix the reference before you trust the sensor.
| Alert | Now | Should be |
|---|---|---|
| Urgent Low Soon · fires ~20 min before a projected <55 | OFF | ON |
| Falling Fast | OFF | ON |
| Urgent Low | 55 | 55 ✓ |
| High | 250 | 200 — inert at 250; make it a canary |
Zero cost. Zero risk. The low alerts stay on as cheap insurance — asymmetry favors keeping them.
C-peptide 1.4 (fasting, June 11 2026 — pre-Frey) with GMI 5.7%. Retained endogenous insulin secretion plus ⟨assumed⟩ impaired glucagon counterregulation would be the configuration that produces a low you cannot sense or self-correct. (Reconciled from the stale 2.1, which was the June 2025 value; 1.4 is still in range, so "retained secretion" holds, but nearer the floor.)
⚠ But glucagon-impairment is UNMEASURABLE — Garbacz 7/15: never tested,
no routine clinical test exists. The low alert stays on regardless; do not describe this as established physiology.
The procedure was an open Frey (head cored out), not a Puestow. The Frey resects the alpha-poor head/uncinate and spares the alpha-rich body and tail — so alpha mass is largely preserved.
But spared mass ≠ preserved function. Kumar 2018 (PMID 30029953, n=30): beta-cell function unchanged at 3 months, alpha-cell function deteriorated post-Frey, independent of mass. So the anatomy line is directionally reassuring, not dispositive. What actually falsifies the hypoglycemia-caution premise is the 180-day behavioral record — zero confirmed real hypos on four glucose-lowering botanicals — not the anatomy.
You are pairing the G7 against a home glucometer at Hct 25.2. At low hematocrit these meters over-read — fewer red cells impede the reaction, so glucose reads falsely high.
The chain: your stick reads high → the sensor looks low → you conclude a negative sensor bias → you gate four reintroductions on an error that lives in the reference standard.
✅ RESOLVED 8/3 — METER VALIDATED. Now on the Accu-Chek Guide, labeled hematocrit range 10–65% (Roche spec) — wider than the retired 20–60% meter and clearing Hct 25.2 with real margin. Accuracy standard is Accu-Chek's 10/10 rule. The G7 is now the instrument being checked and the meter is the reference — the correct direction. Every gate that named "a validated CGM" is released.
| HbA1c | Do not use | Falsely low post-transfusion. Wait ~10–12 weeks. |
| Fructosamine | Use | 2–3 week mean, RBC-independent. Invalid below albumin 3.0; yours is 4.0, so it holds. Draw simultaneous albumin. |
The 180-day aggregate survives: GMI 5.7% and 5.8% across two windows, zero readings above 250.